Na Liu

16.1k total citations · 4 hit papers
319 papers, 9.1k citations indexed

About

Na Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Na Liu has authored 319 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Molecular Biology, 100 papers in Cancer Research and 75 papers in Oncology. Recurrent topics in Na Liu's work include Cancer-related molecular mechanisms research (66 papers), RNA modifications and cancer (55 papers) and MicroRNA in disease regulation (45 papers). Na Liu is often cited by papers focused on Cancer-related molecular mechanisms research (66 papers), RNA modifications and cancer (55 papers) and MicroRNA in disease regulation (45 papers). Na Liu collaborates with scholars based in China, United States and Saudi Arabia. Na Liu's co-authors include Jun Ma, Ying‐Qin Li, Yanhong Zhou, J. Jack Lee, Ying Sun, Qing‐Mei He, Yaqin Wang, Lin Chen, Sergey Leonov and Yulia Merkher and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Na Liu

302 papers receiving 9.1k citations

Hit Papers

Recent advances in therapeutic strategies for tri... 2019 2026 2021 2023 2022 2019 2021 2025 100 200 300 400 500

Peers

Na Liu
Comparison fields: 5 of 159
  • Molecular Biology 5.6k
  • Cancer Research 3.7k
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 1.5k
  • Immunology 899
Xiaohong Wang China
Lorraine O’Driscoll Ireland
Dan Li China
Xin Li China
Sung‐Liang Yu Taiwan
Hailin Tang China
Yongguang Tao China
Chen Liang China
Jian Gu United States
Erik A.C. Wiemer Netherlands
Xiaohong Wang China View profile →
Citations per field, relative to Na Liu
Na Liu · 1×
Citations per year, relative to Na Liu
Na Liu · 1×

Countries citing papers authored by Na Liu

Since Specialization
Citations

This map shows the geographic impact of Na Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Liu more than expected).

Fields of papers citing papers by Na Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Liu. The network helps show where Na Liu may publish in the future.

Co-authorship network of co-authors of Na Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Liu. A scholar is included among the top collaborators of Na Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Liu. Na Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Reactivating T cell immunity in Wnt-hyperactivated non-small cell lung cancer through a supramolecular droplet of carnosic acid and peptide Journal of Pharmaceutical Analysis Na Liu, Y.D. Tu et al. 1
2 Ferrous Fumarate-Encapsulated Nanoformulation Triggering a Domino Effect for Enhanced Ferroptosis Therapy ACS Applied Materials & Interfaces Hui Xu, Na Liu et al. 0
3 DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma Advanced Science Qingjie Li, Xueliang Fang et al. 10
4 The signal peptide of BmNPV GP64 activates the ERAD pathway to regulate heterogeneous secretory protein expression Microbial Cell Factories Na Liu, Ying Xu et al. 1
5 Reversing MET‐Mediated Resistance in Oncogene‐Driven NSCLC by MET‐Activated Wnt Condensative Prodrug Advanced Science Na Liu, Xiaoqiang Zheng et al. 5
6 LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification Ecotoxicology and Environmental Safety Li Rong, Shunle Li et al. 10
7 Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma Cell Death and Disease Xueliang Fang, Qingjie Li et al. 3
8 Treatment duration of wrist-ankle acupuncture for relieving post-thyroidectomy pain: A randomized controlled trial Journal of Integrative Medicine Wei Yue, Huichao Chen et al. 6
9 Chemotherapy‐Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA‐Mediated PKR Activation Advanced Science Qian Li, Cheng Xu et al. 35
10 TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models Nature Communications Yin Zhao, Sha Gong et al. 73
11 Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance Cancer Research Zi‐Qi Zheng, Zhi‐Xuan Li et al. 86
12 Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1 Molecular Cancer Xiao-Hong Hong, Na Liu et al. 159
13 Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers npj Precision Oncology Shouping Liu, Weiwei Lai et al. 13
14 Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3 Cancer Research Zi‐Qi Zheng, Zhi‐Xuan Li et al. 279
15 Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA breakdown → Cell Death and Differentiation Min Wang, Chao Mao et al. 429
16 RAB37 Hypermethylation Regulates Metastasis and Resistance to Docetaxel-Based Induction Chemotherapy in Nasopharyngeal Carcinoma Clinical Cancer Research Ying-Qin Li, Xiao-Jing Yang et al. 24
17 Hypermethylation of SHISA3 Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability Cancer Research Jiän Zhang, Ying-Qin Li et al. 35
18 Inhibition of miR-143 during ischemia cerebral injury protects neurones through recovery of the hexokinase 2-mediated glucose uptake Bioscience Reports Na Liu, Lei Wang et al. 23
19 Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC Cancer Prevention Research Xianyue Ren, Guan‐Qun Zhou et al. 30
20 MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma Molecular Cancer Na Liu, Ning Jiang et al. 103

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026